Diabetes  Manufacturers, Traders, Suppliers

Sinocare’s Technological Breakthroughs and Innovation Directions 1. Breakthrough in Second-Generation CGM (Continuous Glucose Monitoring System)
High-Precision Sensor Technology
The second-generation CGM (i6/i6S for home use, H6 for hospital use) adopts third-generation Direct Electron Transfer (DET) technology, which eliminates oxygen dependency, provides strong anti-interference capability, and ensures high accuracy. The MARD has been reduced to 8.71%, reaching international top-tier standards. Clinical data demonstrate that it can help lower HbA1c by 0.5–1% and reduce the incidence of severe hypoglycemia by over 50%.
Enhanced User Experience
The device features an all-in-one integrated design with a “one-press application” mechanism, requiring no manual assembly. With a thickness of less than 4 mm and a weight of approximately 2 g, it offers a comfortable and discreet wearing experience. The sensor supports daily activities such as showering and exercise, with a battery life of up to 15 days.
Regulatory Approvals and Global Expansion
In December 2024, Sinocare obtained the NMPA Class III registration certificate, and in July 2025, it received EU MDR certification. The product has already been registered and launched in multiple international markets, including Indonesia, the European Union, the United Kingdom, Thailand, and Malaysia, marking an important step in Sinocare’s global deployment.

1. Clinical and Medical Management

• Real-time glucose monitoring for diabetes patients to reduce risks of hypoglycemia and hyperglycemia
• Used in hospitals and clinics for insulin therapy adjustments and diabetes management
• Assists physicians in designing personalized treatment plans

2. Home and Personal Health Management

• Daily glucose monitoring for diabetes patients to support self-management
• Access to glucose data anytime via smartphone or apps, improving treatment adherence
• Enables family members and caregivers to remotely monitor patient glucose levels

3. Public Health and Prevention

• Monitoring glucose trends in high-risk groups (e.g., obese individuals, people with prediabetes)
• Applied in long-term intervention programs and community health management

4. Research and Drug Development

• Used in clinical trials to evaluate the efficacy and safety of new drugs or insulin therapies
• Provides dynamic glucose data for diabetes-related research

5. Sports and Special Population Management

• Athletes and fitness enthusiasts use CGM to optimize nutrition and training plans
• Supports safe glucose management for children and pregnant women with diabetes